Patient-reported health as a prognostic factor for adverse events following percutaneous coronary intervention

Patient-reported health as a prognostic factor for adverse events following percutaneous coronary intervention

Karin Biering,1 Hans Erik Bøtker,2 Troels Niemann,3 Niels Henrik Hjollund4,51Department of Occupational Medicine, Regional Hospital West Jutland, Herning, 2Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, 3Department of Cardiology, Regional Hospital West Jutland, Her...

Full description

Bibliographic Details
Main Authors:	Biering K, Bøtker HE, Niemann T, Hjollund NH
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-01-01
Series:	Clinical Epidemiology
Online Access:	http://www.dovepress.com/patient-reported-health-as-a-prognostic-factor-for-adverse-events-foll-a15661

Similar Items

Self-reported health following percutaneous coronary intervention: results from a cohort followed for 3 years with multiple measurements
by: Biering K, et al.
Published: (2014-12-01)

Return to work after percutaneous coronary intervention: the predictive value of self-reported health compared to clinical measures.
by: Karin Biering, et al.
Published: (2012-01-01)

The SYNTAX score can predict major adverse cardiac events following percutaneous coronary intervention
by: Hadi Safarian, et al.
Published: (2014-01-01)

A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
by: Shuting Kong, et al.
Published: (2021-05-01)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
by: Zhihao Chen, et al.
Published: (2018-11-01)

Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
by: A. V. Svarovskaya, et al.
Published: (2020-07-01)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
by: Hossein Farshidi, et al.
Published: (2018-02-01)

Gender-wise Long-term Predictors for Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly Population
by: A. Siva Ramakrishna, et al.
Published: (2020-02-01)

Factors Associated with Early Adverse Events after Coronary Artery Bypass Grafting Subsequent to Percutaneous Coronary Intervention
by: Yasser Ali Kamal, et al.
Published: (2016-06-01)

Mean Platelet Volume as a Predictor of One-Year Major Adverse Cardiac Events following Elective Percutaneous Coronary Interventions
by: Younes Nozari, et al.
Published: (2015-10-01)

Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention
by: E. Z. Golukhova, et al.
Published: (2016-11-01)

Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes
by: Biering K, et al.
Published: (2015-01-01)

Assessment of prognostic value of Angiographic perfusion score following Percutaneous Coronary Intervention in patients with Acute Coronary Syndrome
by: Alok Sharma, et al.
Published: (2017-11-01)

Major adverse cardiac events and mortality in chronic obstructive pulmonary disease following percutaneous coronary intervention: a systematic review and meta-analysis
by: Pravesh Kumar Bundhun, et al.
Published: (2017-07-01)

Prognostic value of Angiographic Perfusion Score (APS) following percutaneous interventions in acute coronary syndromes
by: V.S. Narain, et al.
Published: (2013-01-01)

The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention
by: Botey Katamu Benjamin, et al.
Published: (2021-01-01)

Percutaneous coronary intervention following Fontan procedure
by: Ahmed Subahi, et al.
Published: (2020-06-01)

Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention
by: Catarina Ramos, et al.
Published: (2014-01-01)

Prognostic Value of Incomplete Revascularization after Percutaneous Coronary Intervention Following Acute Coronary Syndrome: Focus on CKD Patients
by: Thomas Cardi, et al.
Published: (2019-06-01)

Iodide-induced sialadenitis following percutaneous coronary intervention: A case report
by: D Curley, et al.
Published: (2021-06-01)

Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
by: Ching Chen, et al.
Published: (2019-12-01)

A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention
by: Seyed-Ebrahim Kassaian, et al.
Published: (2016-03-01)

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
by: S. Ramesh, et al.
Published: (2020-11-01)

Fractional Flow Reserve following Percutaneous Coronary Intervention
by: Udit Thakur, et al.
Published: (2020-01-01)

Contrast-induced thrombocytopenia following percutaneous coronary intervention
by: Roberto Muniz Ferreira, et al.
Published: (2017-07-01)

The safety of Ramadan Fasting following Percutaneous Coronary Intervention
by: Osama A. Amin, et al.
Published: (2020-11-01)

Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention
by: Pak Lau Chu, et al.
Published: (2011-06-01)

Interplay between genetic and clinical variables affecting platelet reactivity and cardiac adverse events in patients undergoing percutaneous coronary intervention.
by: Jolanta M Siller-Matula, et al.
Published: (2014-01-01)

The relationship between low thiol levels and major adverse cardiovascular events after primary percutaneous coronary intervention in patients with STEMI
by: Oğuz Akkuş, et al.
Published: (2018-05-01)

Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention
by: Lingyun Gu, et al.
Published: (2021-09-01)

The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention
by: Zhaowei Zhang, et al.
Published: (2020-01-01)

Effects of Exercise after Percutaneous Coronary Intervention on Cardiac Function and Cardiovascular Adverse Events in Patients with Coronary Heart Disease: Systematic Review and Meta-Analysis
by: Hu Zhang, Rong Chang
Published: (2019-06-01)

Determinants of clinical outcomes following primary percutaneous coronary intervention : the West Yorkshire Primary Percutaneous Coronary Intervention Outcome Study
by: Krishnamurthy, Arvindra
Published: (2017)

Cardiovascular risk factor control is insufficient in young patients with coronary artery disease
by: Christiansen MK, et al.
Published: (2016-05-01)

Homocysteine and malondialdehyde as predictors of restenosis following percutaneous coronary intervention
by: McNair, Erick
Published: (2006)

Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention
by: Matić Dragan M., et al.
Published: (2015-01-01)

Inflammation during Percutaneous Coronary Intervention—Prognostic Value, Mechanisms and Therapeutic Targets
by: Bradley Tucker, et al.
Published: (2021-06-01)

Development of one-year major adverse cardiac events risk index in patients with acute coronary syndrome and diabetes mellitus who underwent percutaneous coronary intervention
by: Mirković Marija, et al.
Published: (2020-01-01)

Deep Learning-Based Assessment of Adverse Cardiovascular Events in Elderly Patients with Coronary Heart Disease after Percutaneous Coronary Intervention Using Intravascular Ultrasound Images
by: Shu Wang
Published: (2021-01-01)

Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary Intervention
by: Lidija Savic, et al.
Published: (2019-01-01)